Deutsche Bank upgraded Alcon (ALC) to Buy from Hold with a price target of CHF 77, up from CHF 69. The firm views Alcon as the global leader in eye care. The company’s organic sales growth should reaccelerate in 2026 due to a new product launches and margin expansion, the analyst tells investors in a research note. Deutsche believes Alcon represents one of the few investment cases in the sector where growth is not more back-end loaded this year.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALC:
- Seagate upgraded, Tractor Supply downgraded: Wall Street’s top analyst calls
- Alcon downgraded to Hold from Buy at Stifel
- Alcon Walks Away From STAAR Surgical Deal, Reaffirms Refractive Strategy
- Alcon terminates deal to acquire Staar Surgical
- Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix